Literature DB >> 22483697

Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas.

Hiram A Gay1, H Joseph Barthold, Elizabeth O'Meara, Walter R Bosch, Issam El Naqa, Rawan Al-Lozi, Seth A Rosenthal, Colleen Lawton, W Robert Lee, Howard Sandler, Anthony Zietman, Robert Myerson, Laura A Dawson, Christopher Willett, Lisa A Kachnic, Anuja Jhingran, Lorraine Portelance, Janice Ryu, William Small, David Gaffney, Akila N Viswanathan, Jeff M Michalski.   

Abstract

PURPOSE: To define a male and female pelvic normal tissue contouring atlas for Radiation Therapy Oncology Group (RTOG) trials. METHODS AND MATERIALS: One male pelvis computed tomography (CT) data set and one female pelvis CT data set were shared via the Image-Guided Therapy QA Center. A total of 16 radiation oncologists participated. The following organs at risk were contoured in both CT sets: anus, anorectum, rectum (gastrointestinal and genitourinary definitions), bowel NOS (not otherwise specified), small bowel, large bowel, and proximal femurs. The following were contoured in the male set only: bladder, prostate, seminal vesicles, and penile bulb. The following were contoured in the female set only: uterus, cervix, and ovaries. A computer program used the binomial distribution to generate 95% group consensus contours. These contours and definitions were then reviewed by the group and modified.
RESULTS: The panel achieved consensus definitions for pelvic normal tissue contouring in RTOG trials with these standardized names: Rectum, AnoRectum, SmallBowel, Colon, BowelBag, Bladder, UteroCervix, Adnexa_R, Adnexa_L, Prostate, SeminalVesc, PenileBulb, Femur_R, and Femur_L. Two additional normal structures whose purpose is to serve as targets in anal and rectal cancer were defined: AnoRectumSig and Mesorectum. Detailed target volume contouring guidelines and images are discussed.
CONCLUSIONS: Consensus guidelines for pelvic normal tissue contouring were reached and are available as a CT image atlas on the RTOG Web site. This will allow uniformity in defining normal tissues for clinical trials delivering pelvic radiation and will facilitate future normal tissue complication research.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22483697      PMCID: PMC3904368          DOI: 10.1016/j.ijrobp.2012.01.023

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

1.  Dose-wall histograms and normalized dose-surface histograms for the rectum: a new method to analyze the dose distribution over the rectum in conformal radiotherapy.

Authors:  G J Meijer; M van den Brink; M S Hoogeman; J Meinders; J V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-11-01       Impact factor: 7.038

2.  CERR: a computational environment for radiotherapy research.

Authors:  Joseph O Deasy; Angel I Blanco; Vanessa H Clark
Journal:  Med Phys       Date:  2003-05       Impact factor: 4.071

3.  Simultaneous truth and performance level estimation (STAPLE): an algorithm for the validation of image segmentation.

Authors:  Simon K Warfield; Kelly H Zou; William M Wells
Journal:  IEEE Trans Med Imaging       Date:  2004-07       Impact factor: 10.048

4.  A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix.

Authors:  C J Tseng; C T Chang; C H Lai; Y K Soong; J H Hong; S G Tang; S Hsueh
Journal:  Gynecol Oncol       Date:  1997-07       Impact factor: 5.482

5.  Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer.

Authors:  Eugene H Huang; Alan Pollack; Larry Levy; George Starkschall; Lei Dong; Isaac Rosen; Deborah A Kuban
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-12-01       Impact factor: 7.038

6.  Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial.

Authors:  Alan Pollack; Gunar K Zagars; George Starkschall; John A Antolak; J Jack Lee; Eugene Huang; Andrew C von Eschenbach; Deborah A Kuban; Isaac Rosen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-08-01       Impact factor: 7.038

7.  Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy).

Authors:  Cesare Cozzarini; Claudio Fiorino; Giovanni Luca Ceresoli; Giovanni Mauro Cattaneo; Angelo Bolognesi; Riccardo Calandrino; Eugenio Villa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-03-01       Impact factor: 7.038

8.  Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer.

Authors:  Rex Cheung; Susan L Tucker; Jin-Song Ye; Lei Dong; Helen Liu; Eugene Huang; Radhe Mohan; Deborah Kuban
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-04-01       Impact factor: 7.038

9.  Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer.

Authors:  Claudio Fiorino; Giuseppe Sanguineti; Cesare Cozzarini; Gianni Fellin; Franca Foppiano; Loris Menegotti; Anna Piazzolla; Vittorio Vavassori; Riccardo Valdagni
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-11-15       Impact factor: 7.038

10.  Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).

Authors:  T Rancati; C Fiorino; G Gagliardi; G M Cattaneo; G Sanguineti; V Casanova Borca; C Cozzarini; G Fellin; F Foppiano; G Girelli; L Menegotti; A Piazzolla; V Vavassori; R Valdagni
Journal:  Radiother Oncol       Date:  2004-10       Impact factor: 6.280

View more
  127 in total

1.  Dosimetric planning study for the prevention of anal complications after post-operative whole pelvic radiotherapy in cervical cancer patients with hemorrhoids.

Authors:  J G Baek; E C Kim; S K Kim; H Jang
Journal:  Br J Radiol       Date:  2015-09-23       Impact factor: 3.039

2.  A dosimetric comparison of RapidArc and IMRT with hypofractionated simultaneous integrated boost to the prostate for treatment of prostate cancer.

Authors:  K Ishii; R Ogino; W Okada; R Nakahara; R Kawamorita; T Nakajima
Journal:  Br J Radiol       Date:  2013-08-30       Impact factor: 3.039

3.  Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?

Authors:  Mirko Nitsche; Werner Brannath; Matthias Brückner; Dirk Wagner; Alexander Kaltenborn; Nils Temme; Robert M Hermann
Journal:  Br J Radiol       Date:  2016-12-12       Impact factor: 3.039

4.  Dosimetric and volumetric effects in clinical target volume and organs at risk during postprostatectomy radiotherapy.

Authors:  Ahmed Gawish; Ahmed Ali Chughtai; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2018-10-17       Impact factor: 3.621

Review 5.  Quality Control of Radiation Delivery for Lower Gastrointestinal Cancers.

Authors:  Supriya Jain; Karyn A Goodman
Journal:  Curr Treat Options Oncol       Date:  2018-09-07

Review 6.  MRI-only treatment planning: benefits and challenges.

Authors:  Amir M Owrangi; Peter B Greer; Carri K Glide-Hurst
Journal:  Phys Med Biol       Date:  2018-02-26       Impact factor: 3.609

7.  Radiation therapy oncology group gynecologic oncology working group: comprehensive results.

Authors:  David K Gaffney; Anuja Jhingran; Lorraine Portelance; Akila Viswanathan; Tracey Schefter; Joanne Weidhaas; William Small
Journal:  Int J Gynecol Cancer       Date:  2014-06       Impact factor: 3.437

8.  Comparison of dosimetric parameters and acute toxicity after whole-pelvic vs prostate-only volumetric-modulated arc therapy with daily image guidance for prostate cancer.

Authors:  Kentaro Ishii; Ryo Ogino; Yukinari Hosokawa; Chiaki Fujioka; Wataru Okada; Ryota Nakahara; Ryu Kawamorita; Takuhito Tada; Yoshiki Hayashi; Toshifumi Nakajima
Journal:  Br J Radiol       Date:  2016-03-31       Impact factor: 3.039

9.  Dosimetric consequences of interobserver variability in delineating the organs at risk in gynecologic interstitial brachytherapy.

Authors:  Antonio L Damato; Kanopkis Townamchai; Michele Albert; Ryan J Bair; Robert A Cormack; Joanne Jang; Arpad Kovacs; Larissa J Lee; Kimberley S Mak; Kristina L Mirabeau-Beale; Kent W Mouw; John G Phillips; Jennifer L Pretz; Andrea L Russo; John H Lewis; Akila N Viswanathan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-05-03       Impact factor: 7.038

10.  Assessment of acute bowel function after radiotherapy for prostate cancer: Is it accurate enough?

Authors:  M Bonet; L Cayetano; M Núñez; E Jovell-Fernández; A Aguilar; Y Ribas
Journal:  Clin Transl Oncol       Date:  2017-09-12       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.